Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/7/21 → 8/21/25 |
Funding
- SFJ Pharmaceuticals X Ltd: $9,450.00
PB2452 Phase 3 Ticagrelor Reversal Study (PB2452-PT-CL-0004
- Kotter, John (PI)
- Abdel-Latif, Ahmed (Former PI)
| Status | Finished |
|---|---|
| Effective start/end date | 1/7/21 → 8/21/25 |